Relapse Mechanism and Treatment Strategy After Chimeric Antigen Receptor T-Cell Therapy in Treating B-Cell Hematological Malignancies

Over the past few decades, immunotherapy has revolutionized the modern medical oncology field. Chimeric antigen receptor (CAR)-T cell therapy has a promising curative effect in the treatment of hematological malignancies. Anti-CD19 CAR-T cells are the most mature CAR-T cells recently studied and in...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Danni, Jin, Xin, Sun, Rui, Zhang, Meng, Wang, Jiaxi, Xiong, Xia, Zhang, Xiaomei, Zhao, Mingfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Advances in CAR-T Cell Therapies for Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403467/
https://www.ncbi.nlm.nih.gov/pubmed/35989682
http://dx.doi.org/10.1177/15330338221118413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403467/
https://www.ncbi.nlm.nih.gov/pubmed/35989682
http://dx.doi.org/10.1177/15330338221118413

Ejemplares similares